Synergistic effects of insulin and phorbol ester on mitogen-activated protein kinase in Rat-1 HIR cells.
Regulation of the activity of the extracellular signal regulated kinase (ERK) mitogen-activated protein kinases was examined in Rat-1 HIR, a fibroblast cell line overexpressing the human insulin receptor. Insulin or phorbol ester induced partial activations of ERKs, while a combination of insulin and phorbol ester resulted in a synergistic activation. Preincubation with phorbol ester increased the subsequent response to insulin. Phorbol ester did not enhance tyrosine phosphorylation of the insulin receptor. Insulin did not enhance activation of phospholipase D in response to phorbol ester. Lysophosphatidic acid also acted synergistically with insulin to induce ERK activation. Lysophosphatidic acid alone had little effect on ERK, and did not activate phospholipase D. The combination of phorbol ester and insulin maintained tyrosine phosphorylation of focal adhesion kinase, while insulin alone decreased its tyrosine phosphorylation. Phorbol ester induced phosphorylation of She on serine/threonine, while insulin induced tyrosine phosphorylation of She and She-Grb2 binding. These results suggest that full activation of ERKs in fibroblasts can require the cooperation of at least two signaling pathways, one of which may result from a protein kinase C-dependent phosphorylation of effectors regulating ERK activation. In this manner, phorbol esters may enhance mitogenic signals initiated by growth factor receptors.
Knoepp
S M
SM
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston 29425, USA.
Wisehart-Johnson
A E
AE
Buse
M G
MG
Bradshaw
C D
CD
Ella
K M
KM
Meier
K E
KE
D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000302:isolation & purification / Q000378:metabolism*; D002460:Cell Line; D004357:Drug Synergism; D004622:Embryo, Mammalian; D004789:Enzyme Activation; D005347:Fibroblasts; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D007700:Kinetics; D008246:Lysophospholipids / Q000494:pharmacology; D020928:Mitogen-Activated Protein Kinases / Q000302:isolation & purification / Q000378:metabolism*; D004676:Myelin Basic Protein / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000302:isolation & purification / Q000378:metabolism*; D010739:Phospholipase D / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D011972:Receptor, Insulin / Q000096:biosynthesis / Q000502:physiology*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014162:Transfection
D007328:Insulin; D008246:Lysophospholipids; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D011994:Recombinant Proteins; D011972:Receptor, Insulin; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D020928:Mitogen-Activated Protein Kinases; D010739:Phospholipase D; D013755:Tetradecanoylphorbol Acetate